AIM Vaccine Co (6660.HK) Stock Price
AIM Vaccine Co Price
Over the last 6 years AIM Vaccine Co grew revenue by 3.4% annually, reaching 1.36 B CNY. For AIM Vaccine Co, the net margin of -57.9% is down versus -44.1% a few years ago.
AIM Vaccine Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
AIM Vaccine Co business model & stock analysis
Frequently asked questions about AIM Vaccine Co
7 analysts currently rate the AIM Vaccine Co stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect AIM Vaccine Co to generate revenue of 4.32 B CNY and earnings per share of 0.70 CNY.
Converted at the current exchange rate, the AIM Vaccine Co share trades at 0.18 EUR (1.31 CNY).
The expected revenue of AIM Vaccine Co is 4.32 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of AIM Vaccine Co is 863.56 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of AIM Vaccine Co is currently 1.85. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the AIM Vaccine Co stock.
The price-to-sales ratio (P/S) of AIM Vaccine Co is currently 0.37. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the AIM Vaccine Co stock.
The Eulerpool Quality Score for AIM Vaccine Co is 3/10.
The ISIN of AIM Vaccine Co is CNE100005KF2. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of AIM Vaccine Co is 6660.HK. The ticker symbol is used to trade AIM Vaccine Co shares on the stock exchange.
AIM Vaccine Co stock
AIM Vaccine Co Peer Group
AIM Vaccine Co FIGI
All fundamentals and in-depth analysis of AIM Vaccine Co
Our stock analysis for AIM Vaccine Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AIM Vaccine Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.